Lever
Lifestyle
- Regular exercise
- Stress management
- Adequate hydration
Blutwerte · Marker
RDW
Red Cell Distribution Width · Anisozytose-Index
Blutbild
- Einheit:
- %
RDW quantifies the variation in size of red blood cells in a blood sample.
Reference Ranges
Reference
11.5–14.5%
11.5
13.5
14.5
LowNormalHigh
Reference
Optimal
Unit · %Reference ranges may vary slightly based on laboratory standards.
Overview
Übersicht
Red Cell Distribution Width (RDW) is a hematological parameter that measures the variation in size (anisocytosis) of red blood cells (RBCs). It is calculated as part of a standard complete blood count (CBC) and reflects the heterogeneity in erythrocyte size. Clinically, RDW is an important marker as it has been associated with a variety of conditions, including cardiovascular diseases, diabetes, and inflammatory states. Elevated RDW levels have been linked to poor outcomes in conditions such as chronic obstructive pulmonary disease (COPD), acute ischemic stroke, and diabetic kidney disease. Researchers have found that RDW can serve as a prognostic marker for disease severity and mortality in these conditions. In the context of athletic performance and biohacking, RDW may provide insights into overall health and systemic inflammation, potentially affecting recovery and endurance. However, its direct application in these areas requires further research. Caveats in interpreting RDW include its sensitivity to various confounding factors such as age, nutritional status, and underlying chronic diseases. It is not influenced by time-of-day or fasting status, but conditions like anemia or recent blood loss can affect RDW levels, necessitating careful consideration of clinical context when interpreting results.
Klinische Bedeutung
Elevated RDW values can indicate anisocytosis, often associated with conditions like anemia, cardiovascular disease, and systemic inflammation. Lower RDW values are less clinically significant but may suggest a uniform RBC population.
Dynamics
Trend Interpretation
Rising Values
Progressively rising RDW values may suggest worsening anisocytosis, indicating potential underlying conditions such as anemia or inflammation. Retesting in 3-6 months is recommended if values are outside the optimal range.
Falling Values
Falling RDW values may indicate improvement in underlying conditions or stabilization of RBC size variation.
Re-test Interval
3-6 months if outside optimal range
Etiology
Causes — High & Low
Cause
Elevated Levels
- Anemia
- Inflammation
- Cardiovascular disease
- Chronic kidney disease
- Liver disease
Cause
Low Levels
- Uniform RBC population
- Recent blood transfusion
- Certain types of anemia
- Nutritional deficiencies
Protocol
How to Optimize
Lever
Nutrition
- Iron-rich foods
- Vitamin B12 supplementation
- Folate-rich foods
Lever
Supplementation
- Iron supplements
- Vitamin B12
- Folic acid
Note:
Consult a physician before starting any supplementation, especially iron, to avoid toxicity.
Testing Guidelines
✓Fasting Not Required
✓Not Time-Sensitive
Testing Frequency
Annually as part of a complete blood count for healthy adults.
Interfering Factors
- Recent blood transfusion
- Iron supplementation
Open Research Questions
Current research suggests that the clinical utility of RDW as a biomarker in various conditions, such as acute appendicitis and chronic obstructive pulmonary disease, remains debated, particularly regarding reference ranges and confounding factors that may influence its predictive value. Researchers have not yet established optimal RDW targets for risk stratification in diabetic kidney disease and ischemic stroke outcomes. Unanswered clinical questions include the specific mechanisms by which RDW correlates with disease severity and its role in diverse patient populations.
24 Research Publications
167
Total Citations
16
Human/RCT
1.4
Avg. Influence
2025
Latest
Sort
Filter
01Top
#01
The Emerging Clinical Significance of the Red Cell Distribution Width as a Biomarker in Chronic Obstructive Pulmonary Disease: A Systematic Review.
Review
26
This systematic review explored the role of red cell distribution width (RDW) as a biomarker in chronic obstructive pulmonary disease (COPD). Researchers found significant associations between RDW and disease presence, severity, and clinical outcomes, indicating its potential utility in patient risk stratification.
02Top
#02
Association Between Variation in Red Cell Size and Multiple Aging-Related Outcomes.
HumanInfluence1.0
24
Researchers found that greater variability in red blood cell size, indicated by RDW, is linked to increased functional limitations, frailty, and cognitive decline in older men. Higher RDW was also associated with a greater risk of falls and hospitalization. These findings suggest RDW may serve as a marker for biological aging.
03Top
#03
Utility of Red Cell Distribution Width (RDW) as a Noninvasive Biomarker for the Diagnosis of Acute Appendicitis: A Systematic Review and Meta-Analysis of 5222 Cases.
Meta-Analysis
24
This systematic review and meta-analysis evaluated the diagnostic utility of red cell distribution width (RDW) for acute appendicitis (AA). Researchers found no significant difference in RDW values between AA and non-AA cases, suggesting RDW is not a reliable diagnostic marker for AA.
04
#04
Red blood cell distribution width: A marker of anisocytosis potentially associated with atrial fibrillation.
ReviewInfluence1.0
22
This review examined the clinical significance of red cell distribution width (RDW) in patients with atrial fibrillation (AF). Researchers found that elevated RDW values are predictive of AF and may indicate a higher risk of complications, supporting the need for careful monitoring.
05
#05
Association between red cell distribution width/serum albumin ratio and diabetic kidney disease.
Chen Jiaqi, et al. · Journal of diabetes · 2024
HumanInfluence1.0
20
This study examined the relationship between the red cell distribution width/serum albumin ratio (RA) and diabetic kidney disease (DKD). Researchers found that higher RA levels were associated with an increased risk of DKD in diabetic patients, suggesting that RA may serve as an independent predictor for this condition.
Key findings
- 01Higher RA levels in diabetic patients were linked to a greater risk of developing diabetic kidney disease.
- 02The study analyzed data from over 4,500 diabetic patients across two large health databases.
- 03RA may serve as a cost-effective tool for assessing kidney disease risk in diabetes patients.
06
#06
Prognostic value of red cell distribution width in patients undergoing percutaneous coronary intervention: a meta-analysis.
Meta-AnalysisInfluence1.0
9
This meta-analysis evaluated the prognostic value of baseline red cell distribution width (RDW) in patients with coronary artery diseases undergoing percutaneous coronary intervention. Researchers found that elevated RDW was associated with a higher risk of all-cause mortality and major adverse cardiac events. The predictive effect was stronger in patients without anemia.
07
#07
CA125: a new biomarker in patients with Fontan circulation.
HumanInfluence4.0
8
Researchers found that elevated RDW levels are associated with a higher prevalence of complications in patients with Fontan circulation. The study identified RDW as a significant biomarker for predicting clinical failure when combined with other biomarkers.
08
#08
The Role of Red Cell Distribution Width (RDW), RDW/Platelet Ratio, and Mean Platelet Volume as Prognostic Markers in Acute Pancreatitis Severity and Complications Based on the Bedside Index for Severity in Acute Pancreatitis Score.
Human
7
This study investigated the role of red cell distribution width (RDW) and related ratios in predicting the severity of acute pancreatitis (AP). Researchers observed that higher RDW values correlated with increased severity scores, suggesting RDW may help assess AP severity.
09
#09
Red Blood Cells and Human Aging: Exploring Their Biomarker Potential.
Review
6
This review explored the potential of red blood cells, including RDW, as biomarkers of aging. Researchers noted that age-related changes in RDW reflect underlying shifts in blood cell production and function, highlighting the need for further research to establish their clinical utility as aging biomarkers.
10
#10
Systematic literature review and critical analysis of RDW in patients with aortic pathologies.
Lippi Giuseppe, et al. · Current problems in cardiology · 2024
Review
6
This systematic review highlighted the role of RDW as a promising biomarker in aortic pathologies. Researchers observed increased RDW values in patients with aortic diseases, suggesting its potential as a diagnostic and prognostic tool.
Key findings
- 01Researchers observed that RDW values were increased in patients with aortic diseases.
- 02In studies where data was combined, the average RDW difference was significant between patients with complicated aortic conditions and those without.
- 03The findings suggest that RDW may serve as a valuable biomarker for diagnosing and predicting outcomes in aortic pathologies.
Publication Trend
Research publications about RDW over time
9totalTrack your bloodwork in PepStack
Log lab results, track trends and optimize your biomarkers over time.
Legal Disclaimer
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer